ArticleJournal of the American Chemical Society2026
Enzymatic Metal-Hydrogen Atom Transfer with a Cobalt Protoporphyrin Cofactor.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Less is more: miniaturized heme enzymes with broad reactivity.Chemical science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction of unnatural cofactors in biocatalysis may open the door to new reactive enzymatic intermediates, and in turn, new biochemical reactions. Here, we employed a de novo biosynthesized, non-natural cofactor, cobalt protoporphyrin IX (CoPPIX), to generate a mononuclear cobalt hydride in the active site of CYP119, a model P450 enzyme. We show that this cobalt hydride intermediate engages in metal-hydrogen atom transfer (MHAT) reactivity, a well-studied and highly utilized reactivity pattern in synthetic chemistry, but which is not known to operate in Nature. We paired convenient in vivo CoPPIX biosynthesis with a colorimetric screen to enable rapid directed evolution. Thus, we engineered CYP119 for MHAT-mediated deallylation of nitrophenols, with the goal of generating not one prolific catalysis, but a diverse set of MHAT-compatible enzymes. Because many silanes hydrolyze quickly, we additionally sought enzymes that accelerate metal-hydride formation from a more persistent silane. This evolution yielded 80 diverse active site recombinants that catalyze MHAT. Serendipitously, we found many variants reduced the aromatic ring of the colorimetric probe, a reaction not previously known. Detailed mechanistic analysis established this is a radical, MHAT-mediated reductive dearomatization that occurs efficiently under aerobic conditions, albeit on a limited suite of nitrophenyl ethers. These results lay a framework for further engineering and study of biocatalytic MHAT and the unique role of metal substitution to tune reactivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.